Latest News and Press Releases

YieldMax ETFs Announces Weekly Distributions for Group 2 ETFs

GLEN ALLEN, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of...

Key milestones include acquisition of Iverson Design and signing PureWave Hydrogen as first tokenization clientManagement to host business update conference call tomorrow at 10:00 am ET BOSTON, MA,...

Strengthens footprint in high-volume Chesapeake Bay market Adds 150 boat storage capacity, reducing third-party costs Enhances inventory sourcing, reconditioning, and transaction efficiency ...

Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval; Lifeward gains...

YieldMax ETFs Announces Weekly Distributions for Group 2 ETFs

Jails outpace prisons in offering MOUD, but regional disparities and limited treatment access persist across the U.S.Qualitative feedback points to need for greater reentry support, housing, care...

Delivered full-year revenue of $981.3 million, well above upper end of guidance and the highest reported revenue in the Company’s 30-year historyFull-year revenue growth of 4.5%, currency neutral...

Positions Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while...

TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA...